Reuters logo
3 个月前
BRIEF-Jazz Pharma to present key data on sleeping disorder drug at meeting
2017年5月24日 / 晚上8点24分 / 3 个月前

BRIEF-Jazz Pharma to present key data on sleeping disorder drug at meeting

May 24 (Reuters) - Jazz Pharmaceuticals Plc

* Jazz pharmaceuticals to present phase 3 data on jzp-110, an investigational treatment for excessive sleepiness in patients with narcolepsy and with obstructive sleep apnea, during 31st annual sleep meeting Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below